DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Harrison SA, Goodman Z, Jabbar A. et al.
A randomized, placebo-controlled trial of emricasan in patients with NASH and F1-F3 fibrosis.
J Hepatol 2020;
72 (05) 816-827
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.